NEW YORK & CHICAGO–(BUSINESS WIRE)– #MydCombi–Eyenovia has tapped EVERSANA as exclusive distributor of its MydCombi product for pupil dilation in the U.S., pending the product’s FDA approval.
Category: Business
Aura Biosciences Announces Oversubscribed $80 Million Financing
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubscribed $80 million…
KalVista Pharmaceuticals Appoints Nancy Stuart to Board of Directors
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…
Bosma Honors Blinded Veterans Association as its 2021 Community Partner
INDIANAPOLIS–(BUSINESS WIRE)–Bosma today announced the Blinded Veterans Association (BVA) has received the organization’s 2021 Community Partner Award. Rooted in more than 100 years of history, Bosma is a nonprofit organization providing training and…
Global Lenses for Myopia Control Market (2020 to 2025) – by Lens Type, Age, Sales Channel, Distribution Channel, Region and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Lenses for Myopia Control Market – Analysis By Lens Type, Contact Lens, Spectacle Lens, Age, Sales Channel, Distribution Channel, Region, Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and For…
NovaBay Pharmaceuticals to Hold 2020 Fourth Quarter and Full Year Conference Call on March 25
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and 12 months ended December 31, 2020 after market close on Thursday, March 25, 2021 and will hold an inve…
Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis
NEW YORK–(BUSINESS WIRE)– #Optejet–Eyenovia’s MAP™ fixed-combination pharmaceutical for pupil dilation has been shown to be safe, effective and superior in comparative study.
MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
SAN DIEGO–(BUSINESS WIRE)–MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
Visus Therapeutics Announces FDA Acceptance of IND for Presbyopia-Correcting Eye Drop
SEATTLE–(BUSINESS WIRE)–The FDA accepts Visus Therapeutics’ Investigational New Drug Application, allowing the initiation of a Phase 2 study of BRIMOCHOL for presbyopia
Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added E…
Contentsquare Foundation Launches With Mission to Reduce Digital Accessibility Gap
NEW YORK–(BUSINESS WIRE)– #CX–Contentsquare Foundation aims to reduce accessibility gap
Alcon to Host Virtual Capital Markets Day on March 24
GENEVA–(BUSINESS WIRE)–Alcon to Host Virtual Capital Markets Day on March 24
Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseas…
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…
LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for …
Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States
TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first available generic version of AZOPT® (brinzolamide ophtha…
NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova® for the eye care market and CelleRx® Clinical Reset™ for the beauty market, announces that management will …
Standigm Secures $44.5 M in Pre-IPO Funding Round
SEOUL, South Korea–(BUSINESS WIRE)– #AI–Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
National Vision Holdings, Inc. Announces Participation in the Bank of America Consumer and Retail Technology Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to present at the Bank of America Consumer and Retail Technology Conference 2021 on Tuesday, March 9, 2021 at 2:30 p.m. Eastern Time. A …